Skip to main content
Caplight Logo









Leo Cancer Care

Leo Cancer Care

Private
Horley, EnglandHealthcare & Life Scienceshttps://www.leocancercare.com

Last Round

Series D

Jul 8, 2026

Total Funding Raised

$130.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Leo Cancer Care is a healthcare technology company that develops an advanced cancer treatment system aimed at streamlining radiation therapy through integrated 3D imaging and precise energy delivery to targeted tissues.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

upright radiotherapygantry-less radiotherapypatient positioning systemproton therapyphoton therapyparticle therapyradiotherapy systemsfixed beam radiationoncology equipmentmedical imaginghadrontherapycone-beam CTLinac integrationcarbon ion therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leo Cancer Care Comparables

Compare Leo Cancer Care with similar companies based on industry and business-model similarity.

Leo Cancer Care comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
P-Cure Ltd
86%
Ehmet Health
76%
Mevion Medical Systems
74%

Leo Cancer Care Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 8, 2026
VC RoundSep 24, 2025
Series CJun 11, 2024
Series CSep 24, 2023
Series BJul 20, 2021

Key People

Founding team and executive leadership

Lisa James

PA To CEO And Business Support Manager, Office Manager

Executive Team

Stephen Towe

CEO

Executive Team

Andy Harley

Chief Financial Officer

Executive Team

Eric Schloesser

Chief Product Officer

Executive Team

Leo Cancer Care Investors

Notable investors and investment history

Leo Cancer Care investors
InvestorRounds
Eventide FundsSeries D
Junson CapitalSeries B
Device of Tomorrow CapitalSeries B
Serra VenturesSeries B
EDBISeries C
Catalio Capital ManagementSeries C, VC Round
WARFSeries B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 8, 2026

    $65M round led by Yu Galaxy

  • Jun 23, 2026

    Monthly visitors grew 52% MoM, from 4.2K to 6.4K.

Recent news

Latest coverage and updates

  • is_developingSep 27, 2026

    Leo Cancer Care Ltd is developing fixed-beam photon platform.

  • launchesSep 27, 2026

    Leo Cancer Care Ltd launched upright radiotherapy platform on Sep 27th '26.

  • partners_withSep 16, 2026

    Leo Cancer Care Ltd partnered with Imperial on Sep 16th '26.

  • partners_withJul 28, 2026

    Leo Cancer Care Ltd partnered with Centre Léon Bérard on Jul 28th '26.

  • attends_eventJul 24, 2026

    Leo Cancer Care Ltd attended event AAPM 2026 on Jul 24th '26.

Leo Cancer Care Filings

Explore SEC and related filing metadata, where available.

Leo Cancer Care filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Leo Cancer Care's valuation, stock price, and market status.

Is Leo Cancer Care a public or private company?

Leo Cancer Care is a private company.

What is the current stock price of Leo Cancer Care?

Leo Cancer Care is a private company with no public stock price. No recent secondary market data is available.

How much is Leo Cancer Care worth (valuation)?

Valuation information for Leo Cancer Care is not publicly available.

Can I buy Leo Cancer Care stock?

Leo Cancer Care shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Leo Cancer Care's last funding round?

Leo Cancer Care's most recent funding round was Series D on July 8, 2026.

Who are the main investors in Leo Cancer Care?

Key investors in Leo Cancer Care include Catalio Capital Management, WARF, Pureland Global Venture, Alumni Ventures, Yu Galaxy.

Will Leo Cancer Care IPO soon?

No public IPO plans have been announced for Leo Cancer Care.

How can I track Leo Cancer Care secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leo Cancer Care's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHorley, England
Employee Range101
Year Founded2014
Last FundingJul 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?